英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
abstufen查看　abstufen　在百度字典中的解释百度英翻中〔查看〕
abstufen查看　abstufen　在Google字典中的解释Google英翻中〔查看〕
abstufen查看　abstufen　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Breaking News: FDA Approves Two New Treatments for Atopic Dermatitis . . .
    A new nonsteroidal topical On December 16, the FDA approved Vtama (tapinarof) cream (1%), an aryl hydrocarbon receptor agonist and nonsteroidal topical cream from manufacturer Dermavant, an Organon company, for the treatment of atopic dermatitis in adults and children 2 years of age and older
  • Guidelines of care for the management of atopic dermatitis in adults . . .
    For people with atopic dermatitis (AD) refractory to topical therapies, treatment with phototherapy and systemic therapies can be considered Multiple biologic therapies and Janus kinase (JAK)inhibitors have been approved since 2014 to treat AD These guidelines update the 2014 recommendations for management of AD with phototherapy and systemic therapies
  • New Treatment for Atopic Dermatitis - WebMD
    New Treatment for Atopic Dermatitis: Expert Insights, Key Facts Medically Reviewed by Stephanie S Gardner, MD on March 07, 2025 This is a hopeful time for atopic dermatitis treatment In
  • FDA Greenlights New Treatment for Moderate-to-Severe Atopic Dermatitis . . .
    On December 16, 2024, we reported on on the US FDA approval of nemolizumab (Nemluvio; Galderma) for the treatment of patients aged 12 years and older with moderate-to-severe atopic dermatitis in combination with topical corticosteroids (TCS) and or calcineurin inhibitors (TCIs) when the disease is not controlled by topical prescription therapies
  • Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval
    People with moderate-to-severe atopic dermatitis, the most common form of eczema, don’t always get adequate relief from topical treatments like steroid creams and ointments Now they have a new
  • Focused update: Guidelines of care for the management of atopic . . .
    In 2023 and early 2024, the American Academy of Dermatology (AAD) published guidelines on the management of atopic dermatitis (AD) in adults with topical and systemic therapies 1, 2 Recently published evidence and US Food and Drug Administration (FDA) approval of novel topical small molecule and biologic therapies necessitated an update of the previous guidance
  • New Treatment Targets for Atopic Dermatitis - Dermatology Times
    A recent paper published in the Journal of the European Academy of Dermatology and Venereology presents the Aiming High in Eczema Atopic Dermatitis (AHEAD) recommendations, developed by broad expert consensus to set new treatment targets for atopic dermatitis (AD) across all ages and severities Informed by a global patient study and insights from 87 leading dermatologists in 44 countries
  • Atopic Dermatitis Guidelines Update - Dermatology Advisor
    An updated evidence- and consensus-based living guideline on atopic eczema (AE) has been published in the Journal of the European Academy of Dermatology and Venereology The latest edition of the European Guideline (EuroGuiDerm) on AE is the second update to the original 2022 guideline and provides new guidance on systemic therapies for patients with AE
  • The Atopic Dermatitis Pipeline Emerging Treatments
    The Atopic Dermatitis Pipeline Emerging Treatments Beyond cytokine targeting, researchers are exploring therapies that address the skin barrier defect central to atopic dermatitis For instance, new topical agents aim to enhance skin barrier integrity by boosting lipid production or reducing trans-epidermal water loss
  • Emerging Systemic Treatments for Atopic Dermatitis - PMC
    Introduction Atopic dermatitis (AD) is a common chronic or chronically relapsing, intensely pruritic inflammatory skin disease Worldwide, it affects up to 20% of children and 2–8% of adults, who often present a personal or familial history of atopic diathesis [] AD point prevalence appears to be increasing in all continents and slightly higher in female than male individuals (0 6–24 3%





中文字典-英文字典  2005-2009